← Back to Search

Behavioral Intervention

Virtual Group Visits for Type 2 Diabetes (VIDA Trial)

Phase 2
Recruiting
Led By Arshiya Baig, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient must be at least 18 years old
Patient must be English or Spanish speaking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if virtual group visits for patients with type 2 diabetes are helpful.

Who is the study for?
This trial is for adults over 18 with type 2 diabetes and an A1C level above 8%, who also have a cardiovascular condition like high blood pressure, heart disease, or obesity. Participants must be from certain clinics, speak English or Spanish, and their primary care doctor must agree to their involvement.
What is being tested?
The study is testing the effectiveness of virtual group visits as a treatment method for patients with type 2 diabetes. It aims to see if these online meetings can help manage diabetes better than traditional methods.
What are the potential side effects?
Since this trial involves virtual meetings rather than medication or medical procedures, there are no direct side effects related to drugs or surgery. However, participants may experience stress or fatigue from technology use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I speak English or Spanish.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
A1c
Secondary study objectives
Body Mass Index
Low density lipoproteins
Systolic blood pressure

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Virtual Group Visit ArmExperimental Treatment1 Intervention
These subjects will attend 6 monthly virtual group visits hosted by ACCESS or Advocate research staff.
Group II: Usual Care ArmActive Control1 Intervention
These subjects will receive usual diabetes care at ACCESS or Advocate health centers.

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesOTHER
1,401 Previous Clinical Trials
2,459,585 Total Patients Enrolled
University of ChicagoLead Sponsor
1,062 Previous Clinical Trials
839,416 Total Patients Enrolled
ACCESS Community Health NetworkOTHER
6 Previous Clinical Trials
62,020 Total Patients Enrolled
Advocate Health CareOTHER
56 Previous Clinical Trials
1,413,999 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
443 Previous Clinical Trials
1,412,531 Total Patients Enrolled
Midwest Clinicians' NetworkUNKNOWN
1 Previous Clinical Trials
265 Total Patients Enrolled
Arshiya Baig, MDPrincipal InvestigatorUniversity of Chicago
~262 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top